NCT05186350View on ClinicalTrials.gov

SpyGlass Versus ESWL for Large Common Bile Duct Stones

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

January 25, 2023

Conditions
CholedocholithiasisCommon Bile Duct Calculi
Interventions
PROCEDURE

ERCP+ SpyGlass

SpyGlass direct Vision guided laser lithotripsy

PROCEDURE

ESWL+ ERCP

ESWL + Stone removal through ERCP

Trial Locations (1)

31006

Hangzhou First People's Hospital, Hangzhou

All Listed Sponsors
lead

First People's Hospital of Hangzhou

OTHER

NCT05186350 - SpyGlass Versus ESWL for Large Common Bile Duct Stones | Biotech Hunter | Biotech Hunter